Cargando…
Protocol for stage 1 of the GaP study (Genetic testing acceptability for Paget's disease of bone): an interview study about genetic testing and preventive treatment: would relatives of people with Paget's disease want testing and treatment if they were available?
BACKGROUND: Paget's disease of bone (PDB) is characterised by focal increases in bone turnover, affecting one or more bones throughout the skeleton. This disrupts normal bone architecture and causes pain, deformity, deafness, osteoarthritis, and fractures. Genetic factors are recognised to play...
Autores principales: | Langston, Anne L, Johnston, Marie, Robertson, Clare, Campbell, Marion K, Entwistle, Vikki A, Marteau, Theresa M, McCallum, Marilyn, Ralston, Stuart H |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1513223/ https://www.ncbi.nlm.nih.gov/pubmed/16762063 http://dx.doi.org/10.1186/1472-6963-6-71 |
Ejemplares similares
-
Protocol for stage 2 of the GaP study (genetic testing acceptability for Paget's disease of bone): A questionnaire study to investigate whether relatives of people with Paget's disease would accept genetic testing and preventive treatment if they were available
por: Langston, Anne L, et al.
Publicado: (2008) -
Genetic Determinants of Paget’s Disease of Bone
por: Makaram, Navnit S., et al.
Publicado: (2021) -
Paget’s disease: a review of the epidemiology, etiology, genetics, and treatment
por: Banaganapalli, Babajan, et al.
Publicado: (2023) -
Zoledronate in the prevention of Paget’s (ZiPP): protocol for a randomised trial of genetic testing and targeted zoledronic acid therapy to prevent SQSTM1-mediated Paget’s disease of bone
por: Cronin, Owen, et al.
Publicado: (2019) -
Update on the pathogenesis and genetics of Paget’s disease of bone
por: Gennari, Luigi, et al.
Publicado: (2022)